219
Views
13
CrossRef citations to date
0
Altmetric
Original

Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia

& , MD, PhD
Pages 2028-2036 | Received 15 Mar 2006, Accepted 17 Mar 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ming Ni, Jean-Marc Hoffmann, Michael Schmitt & Anita Schmitt. (2016) Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies. Expert Opinion on Biological Therapy 16:9, pages 1113-1123.
Read now

Articles from other publishers (11)

Jean-Marc Hoffmann, Michael Schmitt, Ming Ni & Anita Schmitt. (2017) Next-generation dendritic cell-based vaccines for leukemia patients. Immunotherapy 9:2, pages 173-181.
Crossref
Daniel J. KowalewskiHeiko SchusterLinus BackertClaudia BerlinStefan KahnLothar KanzHelmut R. Salih, Hans-Georg Rammensee, Stefan Stevanovic & Juliane Sarah Stickel. (2014) HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL). Proceedings of the National Academy of Sciences 112:2.
Crossref
Marzia Palma, Lotta Hansson, Aniruddha Choudhury, Barbro Näsman-Glaser, Ingrid Eriksson, Lars Adamson, Eva Rossmann, Karin Widén, Rudolf Horváth, Parviz Kokhaei, Simona Vertuani, Håkan Mellstedt & Anders Österborg. (2011) Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Cancer Immunology, Immunotherapy 61:6, pages 865-879.
Crossref
Sihem Ouasti, Paul J. Kingham, Giorgio Terenghi & Nicola Tirelli. (2012) The CD44/integrins interplay and the significance of receptor binding and re-presentation in the uptake of RGD-functionalized hyaluronic acid. Biomaterials 33:4, pages 1120-1134.
Crossref
Maike Buchner, Philipp Brantner, Natalie Stickel, Gabriele Prinz, Meike Burger, Constance Bär, Christine Dierks, Dietmar Pfeifer, Ariane Ott, Roland Mertelsmann, John G. Gribben, Hendrik Veelken & Katja Zirlik. (2010) The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies. British Journal of Haematology 151:2, pages 167-178.
Crossref
Cornelia Tolg, Sara R. Hamilton, Lyndsey Morningstar, Jing Zhang, S. Zhang, Kenneth V. Esguerra, Patrick G. Telmer, Len G. Luyt, Rene Harrison, James B. McCarthy & Eva A. Turley. (2010) RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity. Journal of Biological Chemistry 285:34, pages 26461-26474.
Crossref
Ovidiu Marina, Ursula Hainz, Melinda A. Biernacki, Wandi Zhang, Ann Cai, Jonathan S. Duke-Cohan, Fenglong Liu, Vladimir Brusic, Donna Neuberg, Jeffery L. Kutok, Edwin P. Alyea, Christine M. Canning, Robert J. Soiffer, Jerome Ritz & Catherine J. Wu. (2010) Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens. Cancer Research 70:4, pages 1344-1355.
Crossref
L. Adamson, M. Palma, A. Choudhury, I. Eriksson, B. Näsman-Glaser, M. Hansson, L. Hansson, P. Kokhaei, A. Österborg & H. Mellstedt. (2009) Generation of a Dendritic Cell-based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large-scale Production. Scandinavian Journal of Immunology 69:6, pages 529-536.
Crossref
Aaron E. Foster, Malcolm K. Brenner & Gianpietro Dotti. (2008) Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia. Best Practice & Research Clinical Haematology 21:3, pages 375-389.
Crossref
Christopher Alan Maxwell, James McCarthy & Eva Turley. (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?. Journal of Cell Science 121:7, pages 925-932.
Crossref
Vera Rebmann, Holger Nückel, Ulrich Dührsen & Hans Grosse-Wilde. (2007) HLA-G in B-chronic lymphocytic leukaemia: Clinical relevance and functional implications. Seminars in Cancer Biology 17:6, pages 430-435.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.